Northern Trust’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41M | Sell |
453,203
-30,686
| -6% | -$231K | ﹤0.01% | 2697 |
|
|
2025
Q1 | $3.66M | Sell |
483,889
-17,019
| -3% | -$129K | ﹤0.01% | 2589 |
|
|
2024
Q4 | $6.1M | Buy |
500,908
+30,023
| +6% | +$366K | ﹤0.01% | 2395 |
|
|
2024
Q3 | $7.88M | Buy |
470,885
+174,033
| +59% | +$2.91M | ﹤0.01% | 2203 |
|
|
2024
Q2 | $5.18M | Buy |
296,852
+32,903
| +12% | +$574K | ﹤0.01% | 2377 |
|
|
2024
Q1 | $4.5M | Sell |
263,949
-2,973
| -1% | -$50.7K | ﹤0.01% | 2533 |
|
|
2023
Q4 | $2.72M | Buy |
266,922
+12,105
| +5% | +$123K | ﹤0.01% | 2824 |
|
|
2023
Q3 | $2.31M | Buy |
254,817
+18,279
| +8% | +$165K | ﹤0.01% | 2864 |
|
|
2023
Q2 | $2.55M | Sell |
236,538
-12,040
| -5% | -$130K | ﹤0.01% | 2872 |
|
|
2023
Q1 | $2.54M | Sell |
248,578
-40,557
| -14% | -$415K | ﹤0.01% | 2832 |
|
|
2022
Q4 | $3.05M | Buy |
289,135
+15,152
| +6% | +$160K | ﹤0.01% | 2768 |
|
|
2022
Q3 | $3.51M | Buy |
273,983
+4,706
| +2% | +$60.3K | ﹤0.01% | 2703 |
|
|
2022
Q2 | $3.45M | Buy |
269,277
+30,334
| +13% | +$389K | ﹤0.01% | 2744 |
|
|
2022
Q1 | $2.5M | Buy |
238,943
+7,560
| +3% | +$79.2K | ﹤0.01% | 2984 |
|
|
2021
Q4 | $3.57M | Buy |
231,383
+2,380
| +1% | +$36.7K | ﹤0.01% | 2902 |
|
|
2021
Q3 | $5.17M | Buy |
229,003
+96,629
| +73% | +$2.18M | ﹤0.01% | 2712 |
|
|
2021
Q2 | $3.41M | Sell |
132,374
-8,866
| -6% | -$228K | ﹤0.01% | 3066 |
|
|
2021
Q1 | $5.89M | Buy |
+141,240
| New | +$5.89M | ﹤0.01% | 2652 |
|